Free Trial
NASDAQ:IZTC

Invizyne Technologies (IZTC) Stock Price, News & Analysis

Invizyne Technologies logo
$13.99 -0.91 (-6.11%)
As of 05/27/2025

About Invizyne Technologies Stock (NASDAQ:IZTC)

Key Stats

Today's Range
$13.24
$15.14
50-Day Range
$9.95
$15.15
52-Week Range
$8.50
$23.00
Volume
10,893 shs
Average Volume
37,647 shs
Market Capitalization
$87.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Invizyne Technologies Inc. is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc. is based in Monrovia, CA.

Receive IZTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invizyne Technologies and its competitors with MarketBeat's FREE daily newsletter.

IZTC Stock News Headlines

Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.
Invizyne announces corporate name change to eXoZymes
Invizyne Technologies Inc trading resumes
Invizyne Technologies Inc trading halted, volatility trading pause
See More Headlines

IZTC Stock Analysis - Frequently Asked Questions

Invizyne Technologies' stock was trading at $16.50 at the beginning of 2025. Since then, IZTC shares have decreased by 15.2% and is now trading at $13.99.
View the best growth stocks for 2025 here
.

Invizyne Technologies (IZTC) raised $15 million in an initial public offering (IPO) on Wednesday, November 13th 2024. The company issued 1,875,000 shares at $8.00 per share.

Invizyne Technologies' lock-up period expired on Monday, May 12th. Invizyne Technologies had issued 1,875,000 shares in its initial public offering on November 13th. The total size of the offering was $15,000,000 based on an initial share price of $8.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Shares of IZTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IZTC
Previous Symbol
NASDAQ:IZTC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$87.47 million
Optionable
N/A
Beta
N/A
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:IZTC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners